IAI CONFERENCE: The development of Origanum vulgare L. into nanoparticles in dosage forms

Introduction: Origanum vulagre L. is known for its abundant essential oil content with monoterpene and sesquiterpene derivatives.    Aims: This research aims to gather comprehensive information about oregano and its potential to be developed into a nanotechnology drug delivery system.    Methods: Literary studies were conducted using data obtained by searching through online literature sources.    Results: Oregano is reported to contain active phytochemicals like esitronellol. In modern scientific literature, its extracts have been reported to have antidiabetic, analgesic, anti-inflammatory, anticancer and other potential properties. Further research needs to be done to ascertain the safety and therapeutic effect of this plant. The development of oregano’s essential oil into nanoparticles in dosage forms can increase its solubility, stability, and pharmacological effects.